Pegasta 6mg Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Pegfilgrastim (6mg)
Overview Pegasta 6mg Injection
Filgrastim 6mg injection combats infection risk following chemotherapy. This growth factor boosts white blood cell production in the bone marrow, bolstering the body's infection defenses. Administration is via injection by a healthcare professional, and treatment duration is determined by your physician based on individual needs and response. Regular blood tests, including white blood cell counts and bone density assessments, may be required. Common side effects include bone and joint pain, headache, nausea, and muscle aches; injection site pain or redness is also frequent. Report any persistent lumps, swelling, or bruising at the injection site. While this medication reduces infection risk, it's not foolproof; notify your doctor immediately if you experience fever, chills, respiratory distress, sore throat, or facial/neck swelling. Inform your healthcare provider of all other medications you're taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding. Reliable contraception is crucial for both partners throughout treatment. Refrain from driving or activities requiring alertness if dizziness occurs.
Uses of Pegasta 6mg Injection
Infectious Disease Prophylaxis Following Chemotherapy
Major Benefits of Pegasta 6mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Pegasta 6mg Injection:
- Bone pain
- Joint pain
- Headache
- Nausea
- Low blood platelets
- Muscle pain
- Back pain
- Pain in extremities
- Injection site pain
How to use Pegasta 6mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Pegasta 6mg Injection works:
Filgrastim 6mg injection promotes white blood cell production in the bone marrow, bolstering the body's infection defenses.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Pegasta 6mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Pegasta 6mg Injection during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administering Pegasta 6mg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Pegasta 6mg Injection.
KidneySAFE IF PRESCRIBED
Pegasta 6mg Injection poses no safety concerns for individuals with renal impairment. No alteration of the Pegasta 6mg Injection dosage is necessary.
LiverCONSULT YOUR DOCTOR
Data regarding Pegasta 6mg Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Pegasta 6mg Injection :
Omit a dose of Pegasta 6mg Injection? Seek medical advice immediately.
Facts to Know About Pegasta 6mg Injection
| Label | Value |
|---|---|
| Chemical Category | Granulocyte colony-stimulating factor |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | G-CSF (granulocyte colony-stimulating factor) |
3,018 People bought this recently